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Investigations on the clonal nature of antibody formation have demonstrated the 
expression of allelic exclusion by lymphoid cells (1),  as well as the production of a 
monospecific,  restricted  population  of  antibody  molecules  by  the  clonal  progeny 
of a  single antibody-forming precursor cell (B  cell)  (2,  3).  1 Recent  studies suggest, 
however,  that  a  single clone may synthesize antibody molecules of the  same  speci- 
ficity which differ in heavy chain class. Thus,  idiotypic determinants, which are con- 
sidered to be a  function of the antibody combining site and therefore a  variable re- 
gion marker  (4),  have been  shown  to  be shared  among the  IgM  and  IgG anti-Sal- 
monella antibodies produced by individual rabbits (5).  Furthermore,  IgG and IgM 
myeloma proteins derived frmn  a  single individual have  been  shown  to  share  idio- 
typic determinants  (6,  7)  while structural studies indicate that  these proteins have 
identical light chains and  heavy chain variable region subgroups  (7-9). These  and 
other  findings  (10,  11)  are consistent with  the  hypothesis that  the  primary amino 
acid sequence of a  single light or heavy chain is encoded by two genes and that the 
synthesis of the polypeptide chain results from a  mechanism  involving translocation 
(11,  12). 
It is conceivable that a  lymphoid cell might "switch" from IgM to IgG antibody 
production while maintaining the  same or similar antibody specificity. That such  a 
switch  mechanism  is operative has  been  implied by  several findings.  Pernis  et  al. 
(13,  14)  have demonstrated that lymphocytes with IgM molecules on the cell mem- 
brane possess, in their cytoplasm, IgG molecules with similar allotypic determinants. 
Several investigators have shown that treatment of lymphoid cells with anti-/z chain 
antisera inhibits the  production of  IgG antibody-forming cells in  response  to  anti- 
genic stimulation  (15-17).  Finally, Nossal et  al.  (18,  19)  noted  that  microdroplets 
containing single antibody-forming cells expressed both  IgM  and  IgG antibodies. 
The studies presented here were conducted to determine whether the clonal 
progeny of a  single stimulated precursor ceil produced antibody of more than 
one heavy chain class in response tO a  defined, haptenic determinant. Analysis 
of  antibodies produced  by splenic foci derived from  the  adoptive trans[er  of 
limiting numbers  of clonal precursor ceils indicated that  foci producing both 
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IgM  and  IgG1  antihapten  antibodies  occurred  at  a  significantly greater  than 
random  frequency. 
Materials and Methods 
Antigens.--The preparation  of Limulus polyphemus hemocyanln  (Hy)  and  2,4-dinitro- 
phenylated hemocyanin  (DNP-Hy) has been  described  previously  (3).  DNP-Hy  contained 
10 tool of DNP per 100,000 g of Hy. 
Animals.--8-10-wk old Balb/c mice  (Carworth  Div.  Becton,  Dickinson,  and  Co.,  New 
York)  were immunized  by an intraperitoneal injection of 0.1  mg of DNP-Hy in  complete 
Freund's adjuvant  (CFA)  and  used  4-6  mo later as  secondary  spleen cell donors.  Balb/c 
recipients for cell transfer were carrier-primed 4--8 wk  before use  by an  intraperitoneal in- 
jection of 0A mg of Hy in CFA (3).  Nonimmune Balb/c mice were used as primary spleen 
cell donors at 8-10 wk of age. 
Cell Transfer.--Donor spleen cell suspensions  were prepared in Dulbecco's modified Eagle's 
medium  using a  Teflon  tissue homogenizer  (3).  Carrier-primed  recipients received intrave- 
nously 0.5-2.0  X  106 viable spleen cells 6 h after 1,000 r total body irradiation from a cesium 
source. 
Spleen Fragment Cullures.--Recipient spleen  fragments  were  cultured  by  methods  de- 
scribed previously (3), and stimulated with 1 ag/ml of DNP-Hy, 10  -7 M for DNP. Culture 
fluids were  collected every 2-3  days  thereafter,  and  analyzed  for  antibody  by  the  radio- 
immunoassay 7, 11, 13, and 15 days after in vitro stimulation. 
RadiMmmunoassay.---The radioimmunoassay of culture fluids for anti-DNP antibody and 
anti-Hy antibody, and the preparation of iodinated, purified rabbit  antimouse Fab fragment 
antibody  has  been  described  previously  (20). MOPC  104E  myeloma  protein  (#,  X)  was 
purified from tumor tissue and  coupled to bromoacetyl cellulose by methods described pre- 
viously.  1 Lambda  protein was  purified from  the urine  of RPC-20  myeloma  tumor-bearing 
mice by the method  of Potter  (21) and  coupled  to cyanogen bromide activated  Sepharose 
(Pharmacia  Fine Chemicals, Piscataway,  N. J.).  MOPC 31c  (T1,  K)  myeloma protein  was 
purified from tumor tissue by methods described previously, 1 and coupled to Sepharose. 
Antisera  specific  for different classes  of mouse immunoglobulin heavy chains,  produced 
in goats  by  immunization with purified  myeloma proteins,  and  adsorbed  to remove cross- 
reactivity with light and heavy chains of other myeloma proteins, were obtained from Meloy 
Laboratories,  Inc., Springfield,  Va.  Goat antimouse #-chain antibody was purified from the 
Meloy anti-# antiserum  by adsorption  on 104E  myeloma protein coupled immunoadsorbent 
and subsequent elution with 0.1  N  acetic acid. I Iodinated goat antimouse/z-chain antibody 
was  passaged  through  a  lambda-protein  coupled  Sepharose  immunoadsorbent.  Goat  anti- 
mouse "yl-chain antibody was purified from the Meloy anti-'y1 antiserum  by adsorption on 
MOPC  3IC  (IgG1)  protein  coupled  immunoadsorbent  and  elution  with  0.008  M  glycyl- 
glycine HC1, 0.3 M for NaC1, pH 2.25. This preparation was iodinated as described previously 
(20). 
The  purified preparations  of  goat antimouse #-chain  antibody  and  goat antimouse "rl- 
chain antibody were shown  to have no demonstrable cross-reactivity for other heavy chain 
determinants or for light chains. This was established by determining that neither iodinated 
purified antibody preparation  bound  to mouse Fab fragment coupled to Sepharose.  Further- 
more, iodinated goat antimouse #-chain antibody did not bind to IgG molecules purified from 
serum  by  DEAE-ce]lulose chromatography  and  coupled  to  bromoacetyl  cellulose. 1 Anti- 
mouse "yl-chain antibody showed  no binding to IgM molecules purified from serum by G200 
Sephadex  gel filtration  and  coupled  to  bromoacetyl  cellulose. 
RESULTS 
Culture  fluids  obtained  11  and  13  days  after  in  vitro  stimulation  of spleen 
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specifically purified antibodies against mouse heavy chain determinants (/~ and 
3'1), and mouse light chain determinant  (Fab fragment). Table I  presents the 
results of such an analysis. 58% of the primary loci produced IgG1 anti-DNP 
antibody;  32% produced IgM  anti-DNP  antibody;  and  16%  produced both 
IgM and IgG1 anti-DNP antibody. While 82 % of the secondary foci produced 
IgG1  anti-DNP  antibody,  no secondary  loci  were  detected  which  produced 
solely  IgM  anti-DNP  antibody.  14%  of  the  secondary  loci  produced  both 
IgM and  IgG1  antihapten antibody. The frequencies of IgM  and IgGi  anti- 
hapten antibody producting primary and secondary foci remained essentially 
the same when culture fluids were analyzed as early as 7 days after stimulation. 
TABLE I 
Analysis of Immunoglobulin Class of Antibody Produced by Splenic Foci 
Anti-DNP antibody detected by  Primary loci  Secondary  foci* 
Foci  Total foci*  Foci  Total loci 
no.  %  no.  % 
Anti-Fab  10  26  7  18 
Anti-Fab or anti-'y1  14  36  25  68 
Anti-Fab or anti-/a  5  13  0  0 
Anti-Fab or anti-2~l or anti-#  5  13  5  14 
Anti-71  2  6  0  0 
Anti-~  l  3  0  0 
Anti-3,1 or anti-#  1  3  0  0 
Total foci detected  38  37 
Total ceils injected  14 X 106  5 X 106 
Total fragments analyzed  336  480 
* All fragments stimulated with  10  -7 M DNP determinant concentration on DNP-Hy. 
Table II presents the frequencies of primary and secondary foci producing 
more than one heavy chain  class of anti-DNP  antibody and  the frequencies 
which  would  be predicted  by a  random  distribution.  It is apparent  that  the 
number of foci obtained which produced both IgM and IgG1 antihapten anti- 
body  is  considerably  higher  than  that  predicted  by  random  occurrence.  In 
contrast,  the number of primary foci producing both anti-DNP  antibody and 
anti-Hy antibody is close to that predicted by a random distribution, 
DISCUSSION 
Previous reports from this laboratory have demonstrated that the number of 
splenic loci detected after transfer of limiting numbers of nonimmune or immune 
spleen cells to carrier-primed recipients is linearly related to the number of cells 
injected,  and  that  the  antihapten  antibodies  produced  by these  foci  are  re- 
stricted  by  the  criteria  of  isoelectric  spectra  and  hapten-binding  properties 
(3). 1 These findings suggest that such primary and secondary splenic foci are 
the result of antibody production by the clonal progeny of a single stimulated 
B  cell. This is in contrast to studies using erythrocyte  antigens,  where  splenic PRESS AND  KLINMAN  BRIEF  DEFINITIVE REPORT 
TABLE II 
(A )  Frequency of Splenic Foci Releasing IgM and IgG1 Anti-DNP Antibody* 
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AntI-DNP antibody  heavy  chain class  Number of 
Primary loci  Secondary foci 
3'1  22  30 
#  12  5 
3'1 and/z  6 (0.8)J~  5 (0.3)// 
Total fragments analyzed  336  480 
(B)  Frequency of Splenic Foci Releasing Anti-DNP and Anti-Hy Antibody* 
Specificity of antibody released per focus  Number of primary  loci 
DNP  102 
Hy  19 
DNP and Hy  4 (2.8)~: 
Total fragments analyzed  570 
* All fragments stimulated with  10  -7 M  DNP determinant  concentration on  1 ~g/ml 
DNP-Hy. 
:~ Number of fragments predicted for random occurrence of two simultaneous, independ- 
ent events. 
foci produced heterogeneous antibodies under conditions of B  cell  excess (22). 
In the studies reported here, the limiting cell for focus formation is the antibody- 
forming precursor cell.  This is reinforced by the finding that after transfer of 
limiting numbers of nonimmune spleen cells  to carrier-primed recipients,  the 
frequency of primary loci producing both antihapten antibody and anticarrier 
antibody is not significantly higher than that predicted by a random event. 
An analysis of the heavy chain class of the antihapten antibody produced by 
these  splenic  loci  indicated  that  16%  of  the  primary loci  and  14%  of  the 
secondary loci produced  both  IgM  and IgG1  anti-DNP  antibody.  Since  the 
observed frequency of these loci is higher than that predicted by a random dis- 
tribution, it is unlikely that the IgM and IgG1 antibody produced by these foci 
is the result of two different hapten-specific B  cells residing in the same frag- 
ment. It would  thus appear that the clonal progeny of a  single precursor cell 
can produce IgM and IgG1 antibody which is specific for a single determinant. 
These studies do not indicate, however, whether the "monofocal"  production 
of IgM and IgG1 antihapten antibody is the result of one or more antibody- 
forming cells within the focus switching from IgM to IgG1 antibody production, 
or whether this is the result of IgM antibody production by some cells of a clone 
while others produce IgG1 antibody. It should be noted that the production of 
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tive evidence for the sharing of heavy chain variable region sequences by these 
antibodies. Such evidence would require analysis of the variable regions of these 
antibodies. 
Less than 20% of the primary or secondary loci which produced IgG1 anti- 
body also produced IgM  antibody, even as early as 7 days after stimulation. 
This finding implies that the production of IgM antibody is not requisite for the 
production of IgG1  antibody by the clonal progeny of a single precursor cell. 
While both primary and  secondary loci produced predominantly IgGi  anti- 
DNP antibody, primary but not secondary loci were detected which produced 
solely IgM antibody. Those secondary loci which produced IgM antibody also 
produced  IgGl  antibody.  The absence  of  secondary loci  making  only IgM 
antibody may denote a qualitative difference between primary and secondary 
DNP-specific precursor cells, and their clonal progeny. 
SUMMARY 
The anti-DNP  antibodies produced by primary and secondary splenic  foci 
were analyzed for heavy chain class by a radioimmunoassay, using iodinated, 
purified goat antimouse ~-chain antibody and goat antimouse 3'1 chainantibody. 
The frequency of primary and secondary loci producing both IgM and IgG1 
anti-DNP antibody (16 % and 14 %, respectively) was considerably higher than 
that which would be predicted by a random distribution. It would thus appear 
that IgM  and IgG1  antibody can be made by the clonal progeny of a single 
precursor cell. 
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